- Home
- ARCT vs CRMD Comparison
ARCT vs CRMD Comparison
Compare ARCT & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARCT
- CRMD
- Stock Information
- Founded
- ARCT 2013
- CRMD 2006
- Country
- ARCT United States
- CRMD United States
- Employees
- ARCT N/A
- CRMD N/A
- Industry
- ARCT Biotechnology: Pharmaceutical Preparations
- CRMD Biotechnology: Pharmaceutical Preparations
- Sector
- ARCT Health Care
- CRMD Health Care
- Exchange
- ARCT Nasdaq
- CRMD Nasdaq
- Market Cap
- ARCT 487.0M
- CRMD 753.6M
- IPO Year
- ARCT N/A
- CRMD 2010
- Fundamental
- Price
- ARCT $15.88
- CRMD $10.15
- Analyst Decision
- ARCT Strong Buy
- CRMD Strong Buy
- Analyst Count
- ARCT 8
- CRMD 6
- Target Price
- ARCT $61.00
- CRMD $15.67
- AVG Volume (30 Days)
- ARCT 405.9K
- CRMD 1.5M
- Earning Date
- ARCT 03-06-2025
- CRMD 03-11-2025
- Dividend Yield
- ARCT N/A
- CRMD N/A
- EPS Growth
- ARCT N/A
- CRMD N/A
- EPS
- ARCT N/A
- CRMD N/A
- Revenue
- ARCT $160,399,000.00
- CRMD $12,262,234.00
- Revenue This Year
- ARCT $7.33
- CRMD N/A
- Revenue Next Year
- ARCT $4.71
- CRMD $246.41
- P/E Ratio
- ARCT N/A
- CRMD N/A
- Revenue Growth
- ARCT N/A
- CRMD 41184.20
- 52 Week Low
- ARCT $14.30
- CRMD $2.89
- 52 Week High
- ARCT $45.00
- CRMD $13.85
- Technical
- Relative Strength Index (RSI)
- ARCT 41.74
- CRMD 40.80
- Support Level
- ARCT $16.03
- CRMD $11.90
- Resistance Level
- ARCT $17.95
- CRMD $12.67
- Average True Range (ATR)
- ARCT 1.29
- CRMD 0.73
- MACD
- ARCT -0.07
- CRMD -0.27
- Stochastic Oscillator
- ARCT 10.29
- CRMD 2.12
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the research and development segment of medical applications for nucleic acid-focused technology. The company's product pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU and LUNAR-COV19.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets.